Literature DB >> 22241724

Surgical repair for abdominal aortic aneurysm concomitant with iliac arterial disease using InterGard™ Quadrifurcated.

Yujiro Ito1, Yoshitsugu Nakamura, Yoshimasa Seike, Satoru Domoto, Osamu Tagusari.   

Abstract

InterGard™ Quadrifurcated [InterVascular S.A. (MAQUET Cardiovascular), La Ciotat, France], a knitted quadrifurcated prosthetic graft, is useful to simplify the procedures for patients with abdominal aortic aneurysm concomitant with iliac arterial disease. From March 2008 to April 2010, 59 patients underwent abdominal aortic aneurysm repair in our department. InterGard™ Quadrifurcated was used in 22 patients (37.3%). All patients were male with a mean age of 72.1 ± 12.1 years (range from 45 to 90 years). Four were emergency cases. Nineteen patients had common iliac arterial lesions, and 19 patients had internal iliac arterial lesions. In addition to abdominal aortic aneurysm repair, reconstruction of bilateral internal iliac arteries was performed in 4 patients, reconstruction of unilateral internal iliac artery in 15 (right 6, left 9), and internal mesenteric artery in 13. There was one hospital death due to nonocclusive mesenteric infarction. There were two complications, which were intestinal perforation and intestinal obstruction. All of these three cases were emergency cases. Computed tomography scan 1 week after operation showed that all reconstructed grafts were patent. Although patients with abdominal aortic aneurysm concomitant with iliac arterial disease had many preoperative comorbidities, surgical results with InterGard™ Quadrifurcated were satisfactory. It is useful to simplify the procedures for these patients.

Entities:  

Mesh:

Year:  2012        PMID: 22241724     DOI: 10.1007/s10047-011-0619-z

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  8 in total

1.  AAA elective treatment indication tactics in EVAR era.

Authors:  Petr Utíkal; Martin Köcher; Jirina Koutná; Petr Bachleda; Petr Drác; Marie Cerná; Eva Buriánková
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2004-12       Impact factor: 1.245

2.  Successful management of aortoiliac aneurysms with a quadrifurcated prosthesis.

Authors:  J S Cruz; J F Teixeira; A R Braga
Journal:  Int Angiol       Date:  2000-09       Impact factor: 2.789

3.  A double bifurcated graft for abdominal aorta and bilateral iliac artery reconstruction.

Authors:  K Akiyama; A Takazawa; J Hirota; H Yamanishi; T Akazawa; T Maeda
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Evaluation of the complexity of open abdominal aneurysm repair in the era of endovascular stent grafting.

Authors:  John A Costin; Daniel R Watson; Steven B Duff; Ardis Edmonson-Holt; Lynne Shaffer; Geoffrey B Blossom
Journal:  J Vasc Surg       Date:  2006-05       Impact factor: 4.268

5.  Isolated iliac artery aneurysms: endovascular versus open elective repair.

Authors:  Georgios A Pitoulias; Konstantinos P Donas; Stefan Schulte; Svante Horsch; Dimitrios K Papadimitriou
Journal:  J Vasc Surg       Date:  2007-08-30       Impact factor: 4.268

Review 6.  Buttock claudication and erectile dysfunction after internal iliac artery embolization in patients prior to endovascular aortic aneurysm repair.

Authors:  H S Rayt; M J Bown; K V Lambert; N G Fishwick; M J McCarthy; N J M London; R D Sayers
Journal:  Cardiovasc Intervent Radiol       Date:  2008-03-13       Impact factor: 2.740

7.  Common iliac artery aneurysm: expansion rate and results of open surgical and endovascular repair.

Authors:  Ying Huang; Peter Gloviczki; Audra A Duncan; Manju Kalra; Tanya L Hoskin; Gustavo S Oderich; Michael A McKusick; Thomas C Bower
Journal:  J Vasc Surg       Date:  2008-06       Impact factor: 4.268

8.  Changing indications and outcomes for open abdominal aortic aneurysm repair since the advent of endovascular repair.

Authors:  Charles S Joels; Eugene M Langan; Charles A Daley; Corey A Kalbaugh; Anna L Cass; David L Cull; Spence M Taylor
Journal:  Am Surg       Date:  2009-08       Impact factor: 0.688

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.